Answers are grounded in this paper and cite their sources.
Recent diagnostic advances allow to identify persons in a pre-symptomatic stage of rheumatoid arthritis (RA), opening the way for a preventive therapeutic intervention, which may potentially be curative. We review and discuss existing biomarkers predictive of future onset of RA. A responsible use of biomarkers in clinical settings will require an integration of blood-based tests, imaging techniques, clinical history, environmental risk factors, and family history.
No takes yet. Share an insight, caveat, or question.
Finckh et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: